315 related articles for article (PubMed ID: 16794200)
1. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
Cox D; Maree AO; Dooley M; Conroy R; Byrne MF; Fitzgerald DJ
Stroke; 2006 Aug; 37(8):2153-8. PubMed ID: 16794200
[TBL] [Abstract][Full Text] [Related]
2. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
Bode-Böger SM; Böger RH; Schubert M; Frölich JC
Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
[TBL] [Abstract][Full Text] [Related]
3. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
[TBL] [Abstract][Full Text] [Related]
4. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
Patrick J; Dillaha L; Armas D; Sessa WC
Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
[TBL] [Abstract][Full Text] [Related]
6. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
Bhatt DL; Grosser T; Dong JF; Logan D; Jeske W; Angiolillo DJ; Frelinger AL; Lei L; Liang J; Moore JE; Cryer B; Marathi U
J Am Coll Cardiol; 2017 Feb; 69(6):603-612. PubMed ID: 28089180
[TBL] [Abstract][Full Text] [Related]
7. Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin Preparations.
Cox D; Fitzgerald DJ
Clin Pharmacol Ther; 2018 Jun; 103(6):1047-1051. PubMed ID: 28905988
[TBL] [Abstract][Full Text] [Related]
8. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
9. Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers.
Dharmasaroja PA; Sae-Lim S
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):649-52. PubMed ID: 20689403
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
[TBL] [Abstract][Full Text] [Related]
11. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
May JA; Heptinstall S; Cole AT; Hawkey CJ
Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
[TBL] [Abstract][Full Text] [Related]
12. Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid.
Haastrup PF; Grønlykke T; Jarbøl DE
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):212-5. PubMed ID: 25469781
[TBL] [Abstract][Full Text] [Related]
13. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
[TBL] [Abstract][Full Text] [Related]
15. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
16. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
Serebruany VL; Malinin AI; Sane DC
Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
[TBL] [Abstract][Full Text] [Related]
17. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences.
Anzellotti P; Capone ML; Jeyam A; Tacconelli S; Bruno A; Tontodonati P; Di Francesco L; Grossi L; Renda G; Merciaro G; Di Gregorio P; Price TS; Garcia Rodriguez LA; Patrignani P
Arthritis Rheum; 2011 Mar; 63(3):850-9. PubMed ID: 21360514
[TBL] [Abstract][Full Text] [Related]
18. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
Schiff M; Hochberg MC; Oldenhof J; Brune K
Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
[TBL] [Abstract][Full Text] [Related]
19. Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers.
Coleman JL; Alberts MJ
Am J Cardiol; 2006 Sep; 98(6):838-41. PubMed ID: 16950199
[TBL] [Abstract][Full Text] [Related]
20. Cumulative antiplatelet effect of low-dose enteric coated aspirin.
Jakubowski JA; Stampfer MJ; Vaillancourt R; Deykin D
Br J Haematol; 1985 Aug; 60(4):635-42. PubMed ID: 3927970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
